Publicaciones en colaboración con investigadores/as de Shanghai Jiao Tong University (1)

2022

  1. The value of disease-free survival (DFS) and osimertinib in adjuvant non-small-cell lung cancer (NSCLC): an international Delphi consensus report

    ESMO Open, Vol. 7, Núm. 5